cbp-1019
Small moleculeexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Mar 14, 2023 (NCT05830097)
Timeline
2020s
- Jan 1, 2023
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06576037 | Phase 1 | Dec 31, 2024 | University of Texas at Houston |
| NCT05830097 | Phase 1/Phase 2 (Phase 2) | Mar 14, 2023 | Coherent Biopharma (Suzhou) Co., Ltd., Peking University |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Coherent Biopharma (Suzhou) Co., Ltd. | For profit | 1 | 1 | 1 | 2023 |
| Peking University | Academic/Hospital | 1 | 0 | 1 | 2023 |
| University of Texas at Houston | Academic/Hospital | 1 | 1 | 1 | 2024 |
3 organizations
Page 1 / 1